TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
Price | 1.485p on 09-05-2025 | at 18:25:05
---|---|
Change | 0.00p 0% |
Buy | 1.49p |
Sell | 1.48p |
Buy / Sell GDR Shares |
Last Trade: | Unknown 134,314.00 at 1.485p |
Day's Volume: | 2,001,685 |
Last Close: | 1.485p |
Open: | 1.485p |
ISIN: | GB00B1VKB244 |
Day's Range | 1.482p - 1.485p |
52wk Range: | 1.425p - 4.85p |
Market Capitalisation: | £8m |
VWAP: | 1.484653p |
Shares in Issue: | 543m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Genedrive (GDR) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 134,314 | 1.485p | OTC Trade |
17:05:49 - 09-May-25 |
Buy* | 212,292 | 1.4885p | Ordinary |
16:17:05 - 09-May-25 |
Sell* | 150,000 | 1.4805p | Ordinary |
16:10:31 - 09-May-25 |
Buy* | 134,314 | 1.4885p | Ordinary |
15:52:22 - 09-May-25 |
Sell* | 150,000 | 1.4805p | Ordinary |
15:50:38 - 09-May-25 |
Sell* | 5,000 | 1.4806p | Ordinary |
15:45:09 - 09-May-25 |
Buy* | 200,701 | 1.4888p | Ordinary |
15:03:57 - 09-May-25 |
Sell* | 22,492 | 1.4805p | Ordinary |
14:34:53 - 09-May-25 |
Buy* | 671 | 1.4895p | Ordinary |
14:15:41 - 09-May-25 |
Sell* | 100,000 | 1.4805p | Ordinary |
13:20:43 - 09-May-25 |
Genedrive (GDR) Regulatory News |
||
Date | Source | Headline |
---|---|---|
2nd May 2025 1:30 pm | RNS | CYP2C19 ID Kit CE-IVD certification update |
2nd Apr 2025 7:01 am | RNS | Additional grant funding under DEVOTE programme |
2nd Apr 2025 7:00 am | RNS | Receipt of R&D tax credit |
1st Apr 2025 7:00 am | RNS | Result of RetailBook Offer |
27th Mar 2025 3:30 pm | RNS | RetailBook Offer |
27th Mar 2025 3:29 pm | RNS | Half-year Report |
27th Mar 2025 3:28 pm | RNS | Equity Fundraise |
17th Mar 2025 11:04 am | RNS | Scottish Government testing programme investment |
14th Mar 2025 7:00 am | RNS | CYP2C19-ID Kit adopted for routine clinical use |
30th Dec 2024 11:54 am | RNS | Result of AGM |